ADC Therapeutics(ADCT)
$1.60+0.09 (+5.96%)
ADCT
ADC Therapeutics hedge funds
$1.60
At close:+0.09 (+5.96%)
Want to see ADCT full AI Analyst Report?
ADC Therapeutics (ADCT) Hedge Fund Trading Activity
441 Followers
Trend: ▲ Hedge Funds Increased Holdings by 337.7K Shares Last Quarter
Hedge Fund Holdings in ADCT
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 BlackRock, Inc. | Added | 12.31% | $7,511,500 | <0.01% | |||
| Marcia Venegas | Platinum Investment Management | Reduced | -41.30% | $622,322 | 0.15% | ||
 Kenneth Tropin | Graham Capital Management, L.P. | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold ADC Therapeutics?
The hedge funds that hold the most shares in ADC Therapeutics are Kenneth Tropin, BlackRock, Inc. and Marcia Venegas.
Are hedge funds buying or selling ADCT?
In the last quarter hedge funds have Increased their holdings in ADC Therapeutics by 337.7K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in ADC Therapeutics stock?
Warren Buffet currently does not own shares in ADC Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
